// App-Quantinova.ai

: Clinical outcomes, mortality, and causes of death in patients with NSTEMI according to heart failure at admission: insights from a large contemporary revascularization trial

Researchers

Presenter

  • B Popovic

Principal Investigators

  • E Sorbets

  • J Abtan

  • M Cohen

  • C Pollack

  • C Bode

  • S D Wiviott

  • M Sabatine

  • S R Mehta

  • Y Elbez

Medical Centers

  • Hospital Brabois of Nancy, Vandoeuvre les Nancy, France

  • GH Bichat Claude Bernard, Paris, France

  • Newark Beth Israel Medical Center, Newark, NJ, United States.

  • Thomas Jefferson University Hospital, Philadelphia, United States of America

  • University of Freiburg, Freiburg, Germany

  • Harvard Medical School - Boston - United States of America

  • Hamilton Health Sciences, Hamilton, ON, Canada

Locations

  • France

  • Germany

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • eptifibatide

  • Otamixaban

  • Heparin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Sanofi

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved